Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide
暂无分享,去创建一个
A. Jeltsch | R. Jurkowska | W. Nelson | O. Lequin | P. Arimondo | L. Halby | A. Rajavelu | A. Guy | C. Ferroud | Thierry Drujon | D. Guianvarc’h | C. Sénamaud-Beaufort | Sophie Ajjan | A. Ceccaldi | Christine Champion
[1] Y. Pommier,et al. Sequence‐specific targeting of IGF‐I and IGF‐IR genes by camptothecins , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] Takayoshi Suzuki,et al. Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors. , 2010, Bioorganic & medicinal chemistry letters.
[3] Kenny K H Ang,et al. Divergent modes of enzyme inhibition in a homologous structure-activity series. , 2009, Journal of medicinal chemistry.
[4] Robert S Illingworth,et al. CpG islands – ‘A rough guide’ , 2009, FEBS letters.
[5] Nadine H. Elowe,et al. Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[6] J. Medina-Franco,et al. Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1 , 2009, ChemMedChem.
[7] A. Shilatifard,et al. An operational definition of epigenetics. , 2009, Genes & development.
[8] M. Szyf. Epigenetics, DNA methylation, and chromatin modifying drugs. , 2009, Annual review of pharmacology and toxicology.
[9] A. Jeltsch,et al. Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins. , 2008, Molecular bioSystems.
[10] Ming-Rong Wang,et al. Anticancer drug discovery targeting DNA hypermethylation. , 2008, Current medicinal chemistry.
[11] P. Arimondo,et al. Targeting MDR1 Gene: Synthesis and Cellular Study of Modified Daunomycin-Triplex-Forming Oligonucleotide Conjugates Able to Inhibit Gene Expression in Resistant Cell Lines , 2008, Molecular Pharmacology.
[12] E. Novellino,et al. Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1. , 2008, Journal of medicinal chemistry.
[13] M. Esteller. Epigenetics in cancer. , 2008, The New England journal of medicine.
[14] R. Blumenthal,et al. Mammalian DNA methyltransferases: a structural perspective. , 2008, Structure.
[15] Xiaodong Cheng,et al. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation , 2007, Nature.
[16] Michael B. Stadler,et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.
[17] Brian K Shoichet,et al. A detergent-based assay for the detection of promiscuous inhibitors , 2006, Nature Protocols.
[18] Xiaodong Cheng,et al. Structure and substrate recognition of the Escherichia coli DNA adenine methyltransferase. , 2006, Journal of molecular biology.
[19] N. Osheroff,et al. Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides , 2006, Nucleic acids research.
[20] H. Stopper,et al. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. , 2006, Cancer research.
[21] Ralf Schirrmacher,et al. Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases. , 2006, Bioconjugate chemistry.
[22] Byron H. Lee,et al. Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1* , 2005, Journal of Biological Chemistry.
[23] Frank Lyko,et al. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. , 2005, Cancer research.
[24] T. Bestor,et al. Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.
[25] T. Kan,et al. Ns strategies: a highly versatile synthetic method for amines. , 2004, Chemical communications.
[26] Manel Esteller,et al. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. , 2003, Cancer research.
[27] C. Chung,et al. Effect of detergent on "promiscuous" inhibitors. , 2003, Journal of medicinal chemistry.
[28] M. Kuwahara,et al. Design and Optimization of Camptothecin Conjugates of Triple Helix-forming Oligonucleotides for Sequence-specific DNA Cleavage by Topoisomerase I* , 2002, The Journal of Biological Chemistry.
[29] C. Bailly,et al. Directing topoisomerase I mediated DNA cleavage to specific sites by camptothecin tethered to minor- and major-groove ligands. , 2001, Angewandte Chemie.
[30] A. Jeltsch,et al. Biotin-Avidin Microplate Assay for the Quantitative Analysis of Enzymatic Methylation of DNA by DNA Methyltransferases , 2000, Biological chemistry.
[31] S. Hanash,et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. , 1988, Journal of immunology.
[32] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[33] Lucia Altucci,et al. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. , 2009, The international journal of biochemistry & cell biology.
[34] Fabienne Dioury,et al. Synthesis of a tricyclic tetraazatriacetic ligand for gadolinium(III) as potential contrast agent for MRI , 2007 .
[35] A. Jeltsch. Molecular enzymology of mammalian DNA methyltransferases. , 2006, Current topics in microbiology and immunology.
[36] Peter A. Jones,et al. Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.